Effects of onabotulinum toxin type A injections in patients with Meige's syndrome

Abstract

Background Meige's syndrome is a type of facial dystonia characterized by the simultaneous occurrence of blepharospasm and oromandibular dystonia. Although botulinum toxin type A (OBTA) injections are the standard treatment, evidence of their effectiveness and safety in this scenario is still lacking.

Keywords

• Meige Syndrome
• Dystonia
• Movement Disorders
• Botulinum Toxins
• Síndrome de Meige
• Distonia
• Transtornos dos Movimentos
• Toxinas Botulínicas